Real-time ticker analysis, price-action alerts, and institutional-grade stock data.
LOS ANGELES--(BUSINESS WIRE)---- $UPST--Upstart Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UPST.
Tesla is considering an all-new SUV, according to a Reuters report.
Eli Lilly's Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration's approval earlier this month, the company said.
Chevron said on Thursday that upstream earnings are expected to rise by $1.6 billion to $2.2 billion in the first quarter versus the fourth quarter of 2025, driven by stronger oil and gas prices amid heightened volatility linked to the Middle East conflict.
LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) announced today that it intends, subject to market and other customary conditions, to offer $1,250 million aggregate principal amount of senior notes due 2031 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by certain wholly-owned subsidiaries of CoreWeave. CoreWeave intends to use the proceeds from the offering of the Notes for general corporate purposes, including, wit.
BARCELONA, Spain--(BUSINESS WIRE)--eDreams ODIGEO (the “Company” or “eDO”) (BME: EDR) (OTC: EDDRF), the world's leading travel subscription platform, today announced the scaling of its Prime subscription offering in South Africa, moving the region into a phase of full-scale expansion. For more than a year, eDO has actively established the Prime proposition among local consumers, generating highly conclusive performance data that validate the market's readiness for a travel subscription model. N.
Occidental Petroleum on Thursday said it has discovered oil at the Bandit prospect in the Gulf of Mexico, about 125 miles south of the Louisiana coast.
The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) has a concentration problem that keeps getting worse.
In an uncertain market, investors have rushed to get in on these players seen as “safer” investments. They operate in the areas of healthcare and retail, selling treatments and products that are essential -- this offers the potential for revenue stability.
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) fell 7% to 320p on Thursday after Peel Hunt downgraded the fuel cell technology developer to 'sell' from...
STAAR Surgical (STAA) expects Q1 net sales to exceed $90M, more than doubling year-over-year, driven primarily by China and double-digit growth in the Americas. Disney plans 1,000 job cuts in marketing overhaul under new CEO.
CoreWeave said on Thursday it has entered into an expanded agreement to provide Meta Platforms with $21 billion in cloud capacity, as the social media giant scales its infrastructure to support increasingly complex AI workloads.
BlackBerry on Thursday forecast first-quarter revenue above estimates, as the Canadian software company's turnaround gains traction on the back of strong demand across its cybersecurity and embedded software divisions.
nLIGHT (NASDAQ:LASR) has risen 837% over the past year, moving from $6.44 to $60.32.
Oil giant Chevron (NYSE:CVX | CVX Price Prediction) trades at $197.41 as of writing.
LOS ALTOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 3:45 p.m. ET.
Sweden's Polestar reported a 7% rise in first-quarter sales volume on Thursday, as the EV maker benefitted from its Europe-focused strategy to drive demand amid tariff-driven uncertainty and high costs.
11:00am: Lingering uncertainty over ceasefire The softer GDP figure suggests slower economic growth as markets head into the conflict with Iran, as well...
Dubai Aerospace Enterprise and Blackstone Credit and Insurance have agreed to launch a joint aircraft leasing investment programme targeting annual deployment of approximately $1.6 billion, the companies said on Thursday.
MIDLAND, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI) today announced the pricing of its previously announced underwritten public offering of 29,850,746 shares of its common stock, par value $0.0001 per share (“Common Stock”), at a price to the public of $3.35 per share, resulting in gross proceeds to the Company of approximately $100 million, before deducting the underwriters' discount and commissions and estimated offering fees and expenses, pursuant to an effective shelf registration statement on Form S-3 (the “Registration Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”).
NEW HAVEN, Conn., April 09, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced progress in its REVOLUTION clinical program for VYD2311, a novel monoclonal antibody investigational candidate for the prevention of symptomatic COVID-19. Invivyd also announced today the discovery and advancement of a novel, potentially first- and best-in-class measles monoclonal antibody candidate for treatment and prevention of measles discovered using Invivyd's proprietary technology.
PORTLAND, Tenn., April 09, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, to be followed by a conference call at 8:00 a.m.
RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.
Regen Therapy ' s 24,000-practitioner network will unlock a fully integrated care ecosystem —featuring Stealth Health ' s licensed prescriber team and specialized therapies, Metabolic Code ®-driven longevity programs and ZEO ScientifiX ' s advanced biologic offerings —delivered through a white-label telemedicine platform embedded directly into clinical practice. DALLAS, April 9, 2026 /PRNewswire/ - Regen Therapy has entered into a strategic partnership with Stealth Health to bring scalable, white-label telemedicine and longevity services to its network of more than 3,000 clinics and 24,000 practitioners across the U.S. In parallel, Regen Therapy has entered into a memorandum of understanding ('MOU") with ZEO ScientifiX, for the establishment of an exclusive scientific and biologics strategic collaboration, pursuant to which ZEO is positioned as the core supplier of advanced biologic therapeutics underpinning the next-generation of regenerative product offerings on Regen's platform.
Calgary, Alberta and Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) ("SuperQ Quantum", "SuperQ", or the "Company"), a global leader in hybrid quantum-classical orchestration and advanced optimization, is pleased to announce its strategic selection as a featured exhibitor within the BC Pavilion at Web Summit Vancouver 2026. The event will be held at the Vancouver Convention Centre from May 11-14, 2026.
Reaching a Definitive Agreement Positions NioCorp to Potentially Sell All of its Planned Critical Minerals Products for the First 10 Years of Operations Agreement Envisions a Separate Potential Strategic Investment by Traxys of up to $30 Million in NioCorp Traxys Plays a Key Role in President Trump's Project Vault, a Strategic U.S. Government-Industry Partnership to Facilitate Sales of Critical Minerals Between Producers and Large Manufacturers CENTENNIAL, CO / ACCESS Newswire / April 9, 2026 / NioCorp Developments Ltd. ("NioCorp ," "our ," or the "Company") (NASDAQ:NB), a leading U.S. developer of critical minerals, today announced that it has entered into a non-binding agreement (the "Term Sheet") with Traxys North America LLC ("Traxys") outlining a long-term marketing and offtake arrangement for NioCorp's remaining planned critical minerals products from its Elk Creek Critical Minerals Project (the "Elk Creek Project").
The RadPro Dev Kit enables Defense Industrial Base (DIB) evaluation of QuickLogic's U.S. fabricated Radiation Hardened RadPro FPGA Demonstration will include the Aurora FPGA User Tools for RTL-to-Bitstream development flow with integrated logic synthesis from Synopsys Synplify® and yosys With this release, the first RadPro FPGA is now silicon-proven, marking a key milestone as the company advances its radiation-hardened FPGA initiative SAN JOSE, Calif., April 9, 2026 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP, Radiation Hardened, Antifuse and ruggedized FPGAs, announced today it will demonstrate its newly released RadPro FPGA development kit in Booth 15 at the 41st Hardened Electronics and Radiation Technology (HEART) Conference April 13–17, 2026 in Shreveport, Louisiana.
HOUSTON, April 9, 2026 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce the following recent activity in its private loan portfolio. During the first quarter of 2026, Main Street originated new or increased commitments in its private loan portfolio of $68.0 million and funded total investments across its private loan portfolio with a cost basis totaling $149.1 million.
DR Power continues to grow its XD Series with the introduction of the XD20 commercial ‑ grade rototiller and the debut of the XD17 commercial ‑ grade stump grinder. SOUTH BURLINGTON, Vt.
HOUSTON, April 9, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE: MSIF) ("MSC Income" or the "Fund") is pleased to announce the following recent activity in its private loan portfolio. During the first quarter of 2026, MSC Income originated new or increased commitments in its private loan portfolio of $38.9 million and funded total investments across its private loan portfolio with a cost basis totaling $54.8 million.
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - NTG Clarity Networks Inc. (TSXV: NCI) (OTC Pink: NYWKF); NTG Clarity ("NTG") is pleased to announce it has received new purchase orders ("POs") and contract renewals totaling approximately $12.3M CAD, showing a continued demand for services and products despite conflict in the region. $12M in contract renewals, expansions, and related purchase orders with existing customers including: $5.5M in purchase orders for offshore software development services.
Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development. TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced the recent publication of a new peer-reviewed article, “Psychedelics and the Quantum Brain: A Falsifiable Hypothesis on Posner Molecules and Spin-Dependent Pharmacology,” in Frontiers in Pharmacology.
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cardiff Lexington Corporation (OTCQX: CDIX), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms , has qualified to trade on the OTCQX® Best Market. Cardiff Lexington Corporation upgraded to OTCQX from the OTCQB® Venture Market.
Industry veteran Ajit Kara joins GXO as Senior Vice President of Account Management GREENWICH, Conn., April 09, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world's largest pure‑play contract logistics provider, announced today that Ajit Kara has joined GXO as Senior Vice President, Account Management, reporting to Chief Commercial Officer Karen Bomber.
New preclinical data for FHD-909 (LY4050784) reinforcing the potential for expansion opportunities in combination with an anti-PD-1 antibody in SMARCA4 (BRG1)-mutant lung cancer
CAMBRIDGE, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that it will present at the 2026 CARB-X Investor Day on April 16, 2026, which precedes the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Munich, Germany.
DENVER, April 09, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen and twenty-six weeks ended February 28, 2026.
CHICAGO, April 9, 2026 /PRNewswire/ -- Old Republic International Corporation (NYSE: ORI) – today announced that it will report financial results for the first quarter of 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call at 3:00 p.m. Eastern time to discuss results.
BUENOS AIRES, AR / ACCESS Newswire / April 9, 2026 / Pampa Energía S.A. (NYSE:PAM)(Buenos Aires Stock Exchange:PAMP) ('Pampa' or the 'Company'), one of Argentina's largest energy companies, participating mainly in the crude oil, gas and power generation value chain, announces that on April 9, 2026 it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the '2025 Annual Report') before the U.S. Securities and Exchange Commission (the 'SEC').
Helping enterprises simplify deployments, adapt connectivity and scale globally in 2026 ATLANTA, April 9, 2026 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE) ("KORE" or the "Company"), the global pure-play Internet of Things ("IoT") hyperscaler and provider of IoT Connectivity, Solutions and Analytics, today announced a new portfolio of SGP.32-compliant connectivity solutions in partnership with Kigen, a global leader in eSIM and remote SIM provisioning - with commercial availability planned for later in 2026. Purpose-built for IoT and based on the GSMA's next-generation eSIM standard, KORE's SGP.32 solutions support a wide range of devices, from high-power gateways to battery-powered sensors, and include a range of connectivity profiles tailored to different operational needs, such as streamlined roaming, resilient multi-network approaches and local connectivity with intelligent failover and recovery - enabling organizations to deploy and manage connected devices globally, while adapting connectivity over time.
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - First Majestic Silver Corp. (NYSE: AG) (TSX: AG) (FSE: FMV) (the "Company" or "First Majestic") announces that total production in the first quarter of 2026 was 3.5 million ounces of silver ("Ag"), 34,341 ounces of gold ("Au"), 15.4 million pounds of zinc ("Zn"), 8.7 million pounds of lead ("Pb") and 262,913 pounds of copper ("Cu"), across the Company's four producing underground mines in Mexico, namely, the Santa Elena Silver/Gold Mine ("Santa Elena"), the Los Gatos Silver Mine ("Los Gatos") (the Company holds a 70% interest in the Los Gatos Joint Venture that owns the mine), the San Dimas Silver/Gold Mine ("San Dimas"), and the La Encantada Silver Mine ("La Encantada"). Q1 2026 PRODUCTION AND OTHER HIGHLIGHTS Quarterly Silver Production (26% of guidance midpoint): The Company produced 3.5 million silver ounces in Q1 2026 compared to 3.7 million silver ounces produced in Q1 2025, representing 26% of the 2026 silver production guidance midpoint.
Reports 10% year-over-year revenue growth for the quarter; returns to top-line growth for fiscal year 2026 Records eighth consecutive quarter of improvement in GAAP net income; reports operating cash flow of $45.6 million, up 9% year-over year QNX reports record quarterly revenue of $78.7 million, up 20% year-over-year and 14% for the full fiscal year; QNX grows royalty backlog to $950 million and achieves Rule of 401 for both the quarter and the full fiscal year Secure Communications returns to year-over-year revenue growth for the quarter, driven by accelerating demand for digital sovereignty solutions and expanding defence budgets WATERLOO, ON / ACCESS Newswire / April 9, 2026 / BlackBerry Limited (NYSE:BB)(TSX:BB) today reported financial results for the three months and fiscal year ended February 28, 2026 (all figures in U.S. dollars and U.S. GAAP, except where otherwise indicated). "Since our leadership transition in 2023, we have been focused on a clear goal: to transform BlackBerry into a profitable growth company.
MARYSVILLE, Ohio, April 09, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that it has completed the sale of its subsidiary The Hawthorne Gardening Company to Vireo Growth, Inc. Hawthorne was acquired by Vireo Growth (CSE: VREO; OTCQX: VREOF) in exchange for Vireo shares that are being held by an independent strategic partner and will be reported in the Company's financial statements among its other investments. The Company also reaffirmed its fiscal 2026 guidance, as the divestiture does not impact the full-year outlook.
Regen Therapy's 24,000-practitioner network will unlock a fully integrated care ecosystem - featuring Stealth Health's licensed prescriber team and specialized therapies, Metabolic Code®-driven longevity programs and ZEO ScientifiX's advanced biologic offerings - delivered through a white-label telemedicine platform embedded directly into clinical practice. DALLAS, TX / ACCESS Newswire / April 9, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical-stage biotechnology company, today announced it has entered into a memorandum of understanding (‘MOU") with Regen Therapy, for the establishment of an exclusive scientific and biologics strategic collaboration, pursuant to which ZEO is positioned as the core supplier of advanced biologic therapeutics underpinning the next-generation of regenerative product offerings on Regen Therapy's platform.
Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco product LOS ANGELES, April 9, 2026 /PRNewswire/ -- IKE Tech LLC ("IKE Tech"), an AI-powered compliance infrastructure company and joint venture among Ispire Technology Inc. (NASDAQ: ISPR), Berify, and Chemular Inc., participated in a formal listening session with the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP). During the session, IKE Tech presented the public health case for point-of-use compliance technology to prevent youth usage of ENDS products, its patented Human Identity Token (HIT) technology, and outlined the need for a regulatory framework addressing software as a tobacco product.
Saskatoon, Saskatchewan--(Newsfile Corp. - April 9, 2026) - Gensource Potash Corporation (TSXV: GSP) ("Gensource" or the "Company"), a fertilizer development company focused on sustainable potash production, is pleased to announce the first closing of a private placement offering of units ("Units") of the Company at a price of $0.15 per Unit (the "Offering"). Each Unit consists of one common share in the capital stock of the Company (a "Common Share") and one Common Share purchase warrant of the Company (a "Warrant").
Oxford, UK and San Jose, California , 9 April 2026 – Oxford BioTherapeutics (“OBT”), is a clinical stage oncology company focused on the discovery and development of immuno-oncology (IO) and Antibody Drug Conjugate (ADC)-based therapies enabled by its OGAP®-Verify platform today announced a multi-year, selective target collaboration with Bristol Myers Squibb (NYSE: BMY, “BMS”) focussed on the discovery and development of novel T-cell engager therapies for solid tumours.
SOUTH SAN FRANCISCO, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the 25th Annual Needham Virtual Healthcare Conference.